Print

In recent human trials for a promising new class of drug designed to target the hepatitis C virus (HCV) without shutting down the immune system, some of the HCV strains being treated exhibited signs of drug resistance. In response, an interdisciplinary team of Florida State University biologists, chemists and biomedical researchers devised a novel genetic screening method that can identify the drug-resistant HCV strains and the molecular-level mechanisms that make them that way –– helping drug developers to tailor specific therapies to circumvent them. Florida State biology doctoral student Feng Yang led the research team. The award-winning scholar earned her Ph.D. in August 2010 and is now a postdoctoral associate at Yale University. Yang designed the CoFIM screening methodology with fellow FSU graduate students, postdoctoral associates and distinguished faculty colleagues –– including Associate Professor Tang; chemistry/biochemistry Professor Timothy M. Logan, director of FSU’s Institute of Molecular Biophysics; and Research Assistant Professor Ewa A. Bienkiewicz, of the FSU College of Medicine, where she directs the Biomedical Proteomics Laboratory. Also featured on: 9/29/2010 - Hepatitis C Research and News Blogspot 9/30/2010 - RedOrbit.com

Print

Print

One of the most significant facilities on the campus is the Brenda and Vernon Smith Center for Medical Education, a branch of the Florida State University where the university’s medical students come to complete their training to become doctors.

Print

Print

Press Release A new Florida State University study found that older adults with Parkinson’s disease altered their gait — stride length, step velocity and the time they spent stabilizing on two feet — when asked to perform increasingly difficult verbal tasks while walking. But the real surprise was that even older adults without a neurological impairment demonstrated similar difficulties walking and talking.
A disruption in gait could place Parkinson’s patients and the elderly at an increased risk of falls, according to the Florida State researchers.

Print

Gerry Maitland, professor of neurology in the College of Medicine, is one of the Florida State University researchers behind a new study of how talking while walking can challenge older adults, with or without a neurological impairment. Read full story.

Print

Print

Local physician James "Trey" Falconer, M.D., has been named the prestigious Guardian of the Mission award recipient, presented by the Florida State University College of Medicine. The award recognizes a physician whose activities have furthered the college's mission to "educate and develop exemplary physicians who practice patient-centered health care, discover and advance knowledge and are responsive to community needs, especially through service to elder, rural, minority and underserved populations."

Print

A new Florida State University study found that older adults with Parkinson’s disease changed their gait—stride length, step velocity, and the time they spent stabilizing on two feet—when asked to perform increasingly difficult verbal tasks while walking. In a study that will be published in the October issue of the International Journal of Speech-Language Pathology, FSU professor Leonard L. LaPointe and co-authors Julie A.G. Stierwalt and Charles G. Maitland, The Florida State university College of Medicine, outline their findings. ALSO FEATURED IN: The Times of India – 9/23/2010 Talking while walking bad for Parkinson's patients Medical News Today – 9/24/10 Talking While Walking Puts Parkinson's Patients At Risk For Falls MedIndia.net – 9/25/2010 Parkinson's Patients Have Trouble Walking and Talking

Print

Press Release Paola Dees, M.D., is among the residents and physicians quoted in a Sarasota Herald-Tribune story detailing how well the College of Medicine’s distributed model produces top-notch doctors.